OCTOBIDPublic Tender GazetteOptimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
synopsis monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- synopsis
- Solicitation number
- RFA-DK-27-136
- Posted
- June 8, 2026
- Response deadline
- October 9, 2026
- Location
- US
- Estimated value
- $1,000,000 USD
- NAICS
- Not supplied
- Source
- grants-gov
Summary
This Notice of Funding Opportunity (NOFO) invites applications for a Research Coordinating Center (RCC) to participate in a consortium of clinical centers that will test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks of AOM use. Such intervention strategies should support the promotion of healthy growth and development; adequate nutritional status/intake, healthy eating and physical activity behaviors; menta…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.